For excessive bleeding during surgery, four-factor prothrombin complex concentrate is more effective and cause fewer side ...

Baxter aims to promote enhanced patient care through the evolution of its latest product, which enables direct accessibility in the operating room.

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of ...

The global hemostats market, valued at US$ 2,744.28 million in 2023, is poised to experience significant growth over the next decade, with projections indicating a market value of US$ 4,568.90 million ...

The hemostat market is projected to experience robust growth over the next decade, with the market expected to grow from a valuation of USD 78.70 million in 2022 to reach an estimated USD 134.43 ...